Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
28.60UNCH (UNCH)
Volume
44,799
Close
28.60UNCH (UNCH)
Volume
544,227
52 week range
20.67 - 42.48
Loading...
  • Open28.75
  • Day High29.08
  • Day Low28.04
  • Prev Close28.70
  • 52 Week High42.48
  • 52 Week High Date05/05/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap3.543B
  • Shares Out123.90M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-6.54

KEY STATS

  • Open28.75
  • Day High29.08
  • Day Low28.04
  • Prev Close28.70
  • 52 Week High42.48
  • 52 Week High Date05/05/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23
  • Market Cap3.543B
  • Shares Out123.90M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-6.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.77
  • P/E (TTM)-10.32
  • Fwd P/E (NTM)-13.47
  • EBITDA (TTM)-285.321M
  • ROE (TTM)-110.45%
  • Revenue (TTM)181.74M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-166.63%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arrowhead Pharmaceuticals Inc

 

Profile

MORE
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting...
Douglass Given M.D., Ph.D.
Independent Chairman of the Board
Christopher Anzalone Ph.D.
President, Chief Executive Officer, Director
Patrick O'Brien J.D.
Chief Operating Officer, General Counsel, Company Secretary
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States

Top Peers

SYMBOLLASTCHG%CHG
IMCR
Immunocore Holdings PLC
65.00UNCHUNCH
ACLX
Arcellx Inc
69.55UNCHUNCH
AXSM
Axsome Therapeutics Inc
79.80UNCHUNCH
MOR
MorphoSys AG
18.14UNCHUNCH
IDYA
IDEAYA Biosciences Inc
43.88UNCHUNCH